Wutah pendapatan kuartal marang kuartal: Nasus Pharma, Ltd. (NSRX)

Lambang korporat lan logo Nasus Pharma, Ltd. (NSRX)

Promotion costs and insurance approvals for delivery systems determine the financial burden, while the data snapshot on the GURU.Markets quarterly revenue growth chart shows that the parameter value reaches 0.00. A unique nasal drug delivery method provides a competitive edge in emergency care, and steady government procurement demand for powder medications creates a reliable profit generator for Nasus Pharma Ltd (NSRX).

Nasus Pharma Ltd (NSRX) - Tambahing pendapatan triwulanan saka 14.08.2025 nganti 20.11.2026

Rincian analitis perusahaan Nasus Pharma, Ltd. (NSRX)

- rega saham lan prakiraan rega para ahli:
- indikator kapitalisasi bursa perusahaan:
Analisis kabeh metrik perusahaan:NSRX - Nasus Pharma, Ltd.
Produk sing diprodhuksi Nasus Pharma Ltd.

This indicator tracks the rate of change in quarterly revenues, determining the business's ability to scale sales and offset inflation through market demand. Analyzing the quarterly growth of commercial revenue allows for portfolio stress-testing, assessing the demand for Nasus Pharma Ltd (NSRX) nasal sprays within the over-the-counter segment during seasonal allergy periods and viral outbreaks.